CA1162856A - Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique - Google Patents

Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique

Info

Publication number
CA1162856A
CA1162856A CA000382065A CA382065A CA1162856A CA 1162856 A CA1162856 A CA 1162856A CA 000382065 A CA000382065 A CA 000382065A CA 382065 A CA382065 A CA 382065A CA 1162856 A CA1162856 A CA 1162856A
Authority
CA
Canada
Prior art keywords
methyl
indole
chlorobenzoyl
acetic acid
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000382065A
Other languages
English (en)
Inventor
Dushan M. Dvornik
Nicole Simard-Duquesne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Priority to CA000382065A priority Critical patent/CA1162856A/fr
Priority to JP57127445A priority patent/JPS5824518A/ja
Application granted granted Critical
Publication of CA1162856A publication Critical patent/CA1162856A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
CA000382065A 1981-07-20 1981-07-20 Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique Expired CA1162856A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA000382065A CA1162856A (fr) 1981-07-20 1981-07-20 Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique
JP57127445A JPS5824518A (ja) 1981-07-20 1982-07-20 糖尿病併発症治療用医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000382065A CA1162856A (fr) 1981-07-20 1981-07-20 Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique

Publications (1)

Publication Number Publication Date
CA1162856A true CA1162856A (fr) 1984-02-28

Family

ID=4120472

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000382065A Expired CA1162856A (fr) 1981-07-20 1981-07-20 Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique

Country Status (2)

Country Link
JP (1) JPS5824518A (fr)
CA (1) CA1162856A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513497A (ja) * 1997-08-08 2001-09-04 メドサン、リセルカ エス．アール．エル． 胃分泌過多および腎損傷の予防作用を有する抗炎症剤の製造のための化合物２−メトキシフェニル−１−メチル−５ｐ−メチルベンゾイル−ピロール−２−アセトアミドアセテートの使用

Also Published As

Publication number Publication date
JPS5824518A (ja) 1983-02-14

Similar Documents

Publication Publication Date Title
US4423075A (en) Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic acid
US5393772A (en) Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
US5602143A (en) Method for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitors
US6117844A (en) Method and composition for antiviral therapy
JP4875491B2 (ja) メトホルミンとスタチンとの組み合わせを含む医薬組成物
EP1243270A1 (fr) Technique visant a réduire la pression intra-oculaire dans l'oeil d'un mammifère par l'administration d'agents de blocage du canal potassium
US4210667A (en) Pharmaceutical preparations containing coumarin carboxylic acid derivatives
JPS5940388B2 (ja) ヒダントイン誘導体治療剤
US4254109A (en) 1H-Benz[de]isoquinoline-2(3H)-acetic acid derivatives
AU709322B2 (en) Use of chloride channel blockers for reducing intraocular pressure
EP0771563B1 (fr) Utilisation des ligandes de récepteur 5-HT1A pour le traitement du glaucome
US4307114A (en) Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
US4442118A (en) Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid
KR920002328B1 (ko) T-세포기능 억제를 위한 3-치환된-2-옥신돌-1-카복스 아마이드
EP0610519A1 (fr) Medicament anti-vih
CA1162856A (fr) Inhibition de l'aldose-reductase grace a l'acide 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole- 3-acetique
EP0610444B1 (fr) Utilisation d'un polyhydroxybenzamide ou de l'un de ses dérivés dans la fabrication d'un médicament destiné au traitement d'infections virales
US5202355A (en) Method of inhibiting aldose reductase in diabetic hosts using phenol derivatives
US4423060A (en) Aldose reductase inhibition by 1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid
US4361582A (en) Aldose reductase inhibition by γ-oxo-8-fluoranthenebutanoic acid
EP0081581B1 (fr) Compositions de traitement du glaucome
CA2084641A1 (fr) Utilisation de la d-fenfluramine et de derives de la fenfluramine dans le traitement de l'hypertension chez des sujets insulino-resistants
US4556668A (en) Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties
US5837709A (en) Use of castanospermine as an anti-inflammatory and immunosupressant agent
EP0444546B1 (fr) Dérivés de l'hydantoine pour l'utilisation comme agents hypoglycémiques et/ou hypolipidémiques

Legal Events

Date Code Title Description
MKEX Expiry